![Survival analysis for total IPF patients according to GAP stage with... | Download Scientific Diagram Survival analysis for total IPF patients according to GAP stage with... | Download Scientific Diagram](https://www.researchgate.net/publication/298797767/figure/fig2/AS:567304767639553@1512267404949/Survival-analysis-for-total-IPF-patients-according-to-GAP-stage-with-Cox-proportional.png)
Survival analysis for total IPF patients according to GAP stage with... | Download Scientific Diagram
![Implementation of guideline recommendations and outcomes in patients with idiopathic pulmonary fibrosis: Data from the IPF-PRO registry - Respiratory Medicine Implementation of guideline recommendations and outcomes in patients with idiopathic pulmonary fibrosis: Data from the IPF-PRO registry - Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d47934f3-6e80-49fd-abbf-03a446106189/ga1_lrg.jpg)
Implementation of guideline recommendations and outcomes in patients with idiopathic pulmonary fibrosis: Data from the IPF-PRO registry - Respiratory Medicine
![Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape](https://s3.amazonaws.com/ajmc/_media/_image/AJMC_ACE0146_IPF_Article01_Figure02.jpg)
Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape
![Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland - Katarzyna Górska, Marta Maskey-Warzęchowska, Małgorzata Barnaś, Adam Białas, Adam Barczyk, Hanna Jagielska-Len, Ewa Jassem, Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland - Katarzyna Górska, Marta Maskey-Warzęchowska, Małgorzata Barnaś, Adam Białas, Adam Barczyk, Hanna Jagielska-Len, Ewa Jassem,](https://journals.sagepub.com/cms/10.1177/20406223221117982/asset/images/large/10.1177_20406223221117982-fig1.jpeg)
Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland - Katarzyna Górska, Marta Maskey-Warzęchowska, Małgorzata Barnaś, Adam Białas, Adam Barczyk, Hanna Jagielska-Len, Ewa Jassem,
![PDF] An Of fi cial ATS / ERS / JRS / ALAT Clinical Practice Guideline : Treatment of Idiopathic Pulmonary Fibrosis : Executive Summary An Update of the 2011 Clinical Practice Guideline | Semantic Scholar PDF] An Of fi cial ATS / ERS / JRS / ALAT Clinical Practice Guideline : Treatment of Idiopathic Pulmonary Fibrosis : Executive Summary An Update of the 2011 Clinical Practice Guideline | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c684687c72bb1328cdf9cccadf8b1d961f766ebd/3-Table2-1.png)
PDF] An Of fi cial ATS / ERS / JRS / ALAT Clinical Practice Guideline : Treatment of Idiopathic Pulmonary Fibrosis : Executive Summary An Update of the 2011 Clinical Practice Guideline | Semantic Scholar
![Idiopathic pulmonary fibrosis associated with circulating autoantibodies: a Chinese cohort of a long-term follow-up study | Chinese Medical Journal Idiopathic pulmonary fibrosis associated with circulating autoantibodies: a Chinese cohort of a long-term follow-up study | Chinese Medical Journal](https://mednexus.org/cms/asset/afbb862b-e699-4879-bece-43d6d251103f/cm9.0000000000001834.png)
Idiopathic pulmonary fibrosis associated with circulating autoantibodies: a Chinese cohort of a long-term follow-up study | Chinese Medical Journal
![Pleuroparenchymal fibroelastosis in idiopathic pulmonary fibrosis: Survival analysis using visual and computer-based computed tomography assessment - eClinicalMedicine Pleuroparenchymal fibroelastosis in idiopathic pulmonary fibrosis: Survival analysis using visual and computer-based computed tomography assessment - eClinicalMedicine](https://www.thelancet.com/cms/attachment/c0e8365a-2a17-4f08-ad71-09caec794f7d/gr1_lrg.jpg)
Pleuroparenchymal fibroelastosis in idiopathic pulmonary fibrosis: Survival analysis using visual and computer-based computed tomography assessment - eClinicalMedicine
![Systematic review of content and quality of idiopathic pulmonary fibrosis review articles | European Respiratory Society Systematic review of content and quality of idiopathic pulmonary fibrosis review articles | European Respiratory Society](https://openres.ersjournals.com/content/erjor/4/4/00156-2018/F1.large.jpg)
Systematic review of content and quality of idiopathic pulmonary fibrosis review articles | European Respiratory Society
![Summary of patient classification according to disease diagnosis and... | Download Scientific Diagram Summary of patient classification according to disease diagnosis and... | Download Scientific Diagram](https://www.researchgate.net/publication/270654150/figure/fig1/AS:601751770132492@1520480210179/Summary-of-patient-classification-according-to-disease-diagnosis-and-fulfillment-of.png)
Summary of patient classification according to disease diagnosis and... | Download Scientific Diagram
![National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care | BMJ Open Respiratory Research National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care | BMJ Open Respiratory Research](https://bmjopenrespres.bmj.com/content/bmjresp/9/1/e001363/F1.large.jpg)
National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care | BMJ Open Respiratory Research
![Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohort - The Lancet Digital Health Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohort - The Lancet Digital Health](https://www.thelancet.com/cms/asset/191c9320-f46d-4757-a7e9-8a193ca9c6a2/gr1.jpg)
Forced vital capacity trajectories in patients with idiopathic pulmonary fibrosis: a secondary analysis of a multicentre, prospective, observational cohort - The Lancet Digital Health
![Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study - The Lancet Respiratory Medicine Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/9ea90046-456f-4c8c-8a00-926d9353e355/gr1_lrg.gif)
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study - The Lancet Respiratory Medicine
![Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study | BMC Pulmonary Medicine | Full Text Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study | BMC Pulmonary Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12890-019-0905-8/MediaObjects/12890_2019_905_Fig1_HTML.png)
Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study | BMC Pulmonary Medicine | Full Text
![Patient journey and treatment patterns in adults with IPF based on health care data in Sweden from 2001 to 2015 - Respiratory Medicine Patient journey and treatment patterns in adults with IPF based on health care data in Sweden from 2001 to 2015 - Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/13534536-e301-49f8-b30b-d043b579287f/gr1_lrg.jpg)
Patient journey and treatment patterns in adults with IPF based on health care data in Sweden from 2001 to 2015 - Respiratory Medicine
![Occupational and environmental risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analyses | Scientific Reports Occupational and environmental risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analyses | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-81591-z/MediaObjects/41598_2021_81591_Fig1_HTML.png)
Occupational and environmental risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analyses | Scientific Reports
![Meta‐analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis | Semantic Scholar Meta‐analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/53ba76fd8c9e7a0a6259cd8ac53746cfb3b8766e/6-Table1-1.png)
Meta‐analysis of Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis | Semantic Scholar
![Effects of supplementation of vitamins D, C and E on Idiopathic Pulmonary Fibrosis (IPF): A clinical trial - Clinical Nutrition ESPEN Effects of supplementation of vitamins D, C and E on Idiopathic Pulmonary Fibrosis (IPF): A clinical trial - Clinical Nutrition ESPEN](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/daff8330-bbd0-4379-a951-65d9d0088804/gr1_lrg.jpg)
Effects of supplementation of vitamins D, C and E on Idiopathic Pulmonary Fibrosis (IPF): A clinical trial - Clinical Nutrition ESPEN
![Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis | Scientific Reports Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-92098-y/MediaObjects/41598_2021_92098_Fig1_HTML.png)
Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis | Scientific Reports
![New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis | Scientific Reports New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-05138-6/MediaObjects/41598_2022_5138_Fig1_HTML.png)
New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis | Scientific Reports
![Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape Overview of Idiopathic Pulmonary Fibrosis, Evidence-Based Guidelines, and Recent Developments in the Treatment Landscape](https://s3.amazonaws.com/ajmc/_media/_image/AJMC_ACE0146_IPF_Article01_Table05.jpg)